MUSCLE OXYGENATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE DURING
WALKING WITH AND WITHOUT AN ANKLE FOOT ORTHOSIS
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PURPOSE

1,2
Myers

RESULTS

• To measure the muscle oxygenation of the calf muscle in patients with
peripheral artery disease (PAD) during walking with and without an
ankle foot orthosis (AFO).
• The StO2 at ICT was 36.97%
higher, a significant increase
while using the AFO compared
to NAF (p = 0.016).

INTRODUCTION
• PAD is caused by atherosclerotic plaques that limit blood flow to the
1
lower extremities .
• Claudication, walking-induced pain in the legs, is the most common
2
manifestation of PAD .
• The times of claudication pain onset and at which claudication pain
forces patients to stop walking are known as initial (ICT) and absolute
claudication times (ACT), respectively.
• Muscle oxygenation is significantly lower at rest, and it declines faster in
3
the calf muscles of patients with PAD compared to healthy controls .
• An ankle foot orthosis (AFO) can improve muscle oxygen levels in
patients with PAD by absorbing and returning mechanical force, thus
decreasing calf muscle demand during walking.

• Similarly, at ACT the StO2
significantly increased 30.19%
for AFO trial (p = 0.029).
• This suggests using the AFO
improves
the
oxygenated
hemoglobin delivery to working
muscle
during
exercise,
providing a mechanism for
increased walking distances
while using the AFO.

METHODS

• Patients were recruited through the clinic at the Nebraska-Western
[5]
Figure 1: The StO2 percentage at ICT and ACT for
Iowa Veterans Affairs Medical Center.
both
NAF
and
AFO
trials.
*
indicates
statistically
• A muscle oxygen monitor (PortaMon, Artinis Medical System) was
significant difference between NAF and AFO (p < 0.05).
attached to patient’s gastrocnemius.
• Subjects performed the Gardner maximum walk test on a treadmill
CONCLUSION
(0.89 m/s (2.0 mph) that began at 0% grade and increased 2% grade
every two minutes).
• Our results demonstrate that using the AFO significantly improved the muscle oxygenation
• Subjects verbally indicated the onset of pain (ICT) and when they were in calf muscle in patients with PAD.
no longer able to walk (ACT).
• Future studies should examine how StO2 impacts physical activity, muscle activity, lower
• The subjects performed the protocol twice, once without AFO (NAF) extremity torque and power, and energy cost.
and once while wearing the AFO (AFO).
• Muscle oxygen
was recorded at
both AFO and
compared by a
test (p < 0.05).

saturation, StO2,
ICT and ACT for
NAF trials and
paired-sample t-

REFERENCES

Table 1. Patients Demographics
n

Age (years)

BMI (kg/m2)

7

70.75 ± 6.58

32.64 ± 7.45

[1] Mozaffarian et al. Circulation 54, 133447, 2016. [2] Fowkes et al. Lancet 40,
382-1329, 2013. [3] Mesquita RC, et al.
Journal of Biomedical Optics 18(5),
57007, 2013.

ACKNOWLEDGEMENTS

• This study was supported by NIH grants
(R01AG034995 and R01HD090333).
• Ottobock donated some of the AFOs used in
the study.

